MedPath
Found 1 clinical trials|View Analysis
Sort by:

A Study of TAS-120 in Patients With Metastatic Breast Cancer

Phase 2
Completed
Conditions
Metastatic Breast Cancer
FGFR 1 High Amplification
FGFR2 Amplification
Interventions
First Posted Date
2019-07-18
Last Posted Date
2024-12-06
Lead Sponsor
Taiho Oncology, Inc.
Target Recruit Count
168
Registration Number
NCT04024436
Locations
🇺🇸

BIDMC, Boston, Massachusetts, United States

🇺🇸

Tennessee Oncology, Nashville, Tennessee, United States

🇺🇸

USCF, San Francisco, California, United States

and more 30 locations
© Copyright 2025. All Rights Reserved by MedPath